Alerts will be sent to your verified email
Verify Email
WINDLAS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Windlas Biotech Limited is a leading pharmaceutical CDMO company in India, offering a wide range of development and manufacturing services of high-quality and cost-effective products globally, along with branded products in trade generics and OTC markets.
Windlas Biotech major competitors are Kwality Pharma, Shukra Pharma, Amrutanjan Healthcar, NGL Fine-Chem, Hester Biosciences, TTK Healthcare, Indoco Remedies.
Market Cap of Windlas Biotech is ₹1,605 Crs.
While the median market cap of its peers are ₹1,520 Crs.
Windlas Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Windlas Biotech is 6.32 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Feb | May Aug Nov | Mar Jun Sep Dec | Sep Dec | |||||||||||||||
| Investor Presentation | Feb | May Aug Nov | Mar Jun Sep Dec | Feb Mar May Jun Sep Dec | Feb Mar May Jun Aug Sep Nov | Jun Sep Dec | |||||||||||||
| Conference Call | Feb | Mar Jun Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
